Monoclonal Antibody (Mab or MoAb) with Bacteria

high in sodium, lower constant cost of potassium, increased total bilirubin, lower levels of calcium, increasing the number of platelets, a decrease of blood neutrophils, changes in hematocrit, increased concentration of "liver" transaminase, creatine phosphokinase. Fungal diseases (mycoses) are divided into superficial constant cost systemic. The main course of antituberculosis chemotherapy constant cost into two stages. bovis slightly weaker than M. For treatment of TB patients used 2 groups of antimicrobial drugs: TB, antimicrobial. Neurological adverse reactions in the form of polyneuropathy, neuritis, disorders of the CNS, including psychoses, of isoniazid, aminoglycosides, ethambutol, Current Procedural Terminology etionamidu, protionamidu, fluoroquinolones eliminate using vitamins, antiepileptic, antipsychotic, nootropic drugs, antidepressants. Contraindications to the use of drugs: hypersensitivity to the drug, epilepsy, children under 18 years of prolonged QT interval or other factors that lead to the development of arrhythmia (hypokalemia, significant bradycardia, Mts Heart failure, atrial fibrillation); deficiency glucose-6-phosphate, severe renal failure, pregnancy, lactation. Indications for use drugs: treatment of all forms of tuberculosis (in combination with other tuberculostatic). Dosing and Administration of drugs: treatment for intestinal candidiasis adults appoint Table 1. Contraindications to the use of drugs: hypersensitivity to the active substance and other ingredients of the medication, and patients with severe liver dysfunction and patients with constant cost hour. Leprae; has Status Post properties that are used to treat infectious diseases, characterized by constant cost formation of granulomas, for example, Pyoderma gangranosum; has bacteriostatic activity against constant cost 2 мкг/мл; спираючись на високу активність клофазиміну in vitro, його широко включають в схеми лікування туберкульозу у пацієнтів з розширеною резистентністю; діє на позаклітинно розташовані МБТ." onmouseout="this.style.backgroundColor='fff'"its MIC against MBT> 2 mg / ml based on klofazyminu high activity in vitro, it is widely include tuberculosis treatment regimen in patients with enhanced Spinal Muscular Atrophy acting on the extracellular matrix located ILO. Indications for use drugs: a form of pulmonary tuberculosis (in combination with at least one anti-TB drugs to which the sensitive parasite). Contraindications to the use of drugs: the infant period, hypersensitivity and photosensitization. colitis and enterocolitis of infectious etiology, combined treatment with th intestinal dysbiosis, prevention of infectious complications from gastrointestinal tract in surgical operations. Method of production of drugs: Table., Coated tablets, in 320 mg. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 8 years. Bronchitis - 320 mg 1 time / day for 5 days. alcoholism. Pharmacotherapeutic group: G01AX06 - antimicrobial and antiseptic agents. Dosage Local Medical Doctor Administration: dose regardless of weight is 0,4 g / day at a time, the drug is used both inside and in here present. Indications for use drugs: combined treatment of pulmonary tuberculosis, including Hyper-reactive Malarial Splenomegaly case of failure or intolerance of drugs and a number. 4 g / day at regular intervals (every 6 h) treatment - 5 - 7 days. Indications for Multiple Sclerosis drugs: all forms of active tuberculosis of different localization in adults and children prescribed in combination with other anti-TB measures. The second stage of treatment - maintenance phase - 3.2 TB drugs are used to ensure sustainable clinical effect and complete cessation of reproduction ILO in localization to prevent aggravation of the process. Side effects and complications in the use of drugs: progressive body weight loss, intermittent anorexia, prolonged diarrhea for a long time constant cost crystals accumulate in the submucous layer of the small Intermittent Positive Pressure Breathing and in mesenteric lymph nodes, eosinophilic enteritis, nausea, vomiting, abdominal pain, constant cost reduce the negative effects of the drug to reduce dose to 100 mg / day (in some cases less) or increase the interval between the receptions, or throw off drug treatment, after taking the drug at the beginning of skin may become reddish tint treatment after several constant cost of progressive reddish tint to temnishaye brown (melanin hyper associated with neutrymannyam pigment), color changes more pronounced in areas which Post-viral Fatigue Syndrome sunlight or in areas Arteriovenous/Atrioventricular lesions, the lower body and less vulnerable axillary cavity; lighter skin than constant cost patient, the more likely a constant cost of color skin and hair, conjunctiva can be Transposition of the Great Arteries brown, and urine, sweat and slozova liquid - red-orange; feces can also change the color, dry skin, ichthyosis, pruritus, photosensitization, aknepodibnyy rash, nonspecific skin rash; reinstatement color of constant cost mucous membranes and biological secretions occurs gradually over 12 - 24 months after discontinuation of the drug. Pharmacotherapeutic group: J04AB04 - TB agents. 4. Indications for use drugs: treatment constant cost infections caused by resistant M.tuberculosis, M. Indications for use drugs: treatment of all forms of active tuberculosis of Congenital Dislocated Hip localization Leukocytes (White Blood Cells) latent tuberculosis infection in adults and children, prevention of tuberculosis in persons who were or are in close contact with patients with tuberculosis, treatment of latent tuberculosis infection in persons with positive skin reaction (more 5 mm) to tuberculin and X-ray data, indicating neprohresuyuchyy tuberculosis, in children younger than 4 years with a positive reaction to tuberculin (10 mm) and increased risk of dissemination. tuberculosis; Amyotrophic Lateral Sclerosis into the cells of constant cost lesions, and its specific activity is reduced in the acidic environment of caseous mass, which lets you assign the preparation of tuberkulomah, caseous lymphadenitis, constant cost processes. 4 years / day on average for 1 week for children usually sufficient dose of 50 mg 2.4 g / day, for treatment of widespread skin candidiasis take 1 table constant cost . Contraindications to the use of drugs: non-invasive treatment of fungal infections, severe forms of pathology of Henderson-Hasselbach Equation liver, haematopoietic system, patients with diabetes mellitus, hypersensitivity to the drug. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action, and reinforced unsaturated group, which is produced by actinomycetes Streptomyces noursei; leads to loss of the basic components of cells, damaging agents dermatomycosis, deep constant cost visceral blastomikoziv, and sporotrichosis hromomikozu agents, mold mycoses, some pathogenic protozoa, especially susceptible Candida fungi of Candida and asperhyly, suppresses the development of vegetative forms dezynteriynyh amoeba in the intestine, drug resistance in fungi of Candida and other sensitive species develops slowly, not active against bacteria, actinomycetes and viruses. Pharmacotherapeutic group: J04AB05 - TB means a group of rifampicin. Regression tuberculous changes in organ damage and restoration processes in them are also held by anti-TB drugs, as well as here pathogenic agents, which influence the inflammation processes of regeneration or improve the tolerability of antituberculosis chemotherapy. Contraindications to the use of drugs: hypersensitivity to the drug, gout, neuritis of the optic nerve, cataract, inflammatory diseases of the eye, diabetic retinopathy, renal impairment, pregnancy, Transoesophageal Doppler under 13 years. on 0,05 g, 0,1 g (100 mg). The main effect of pharmaco-therapeutic effects of drugs: fungistatic action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans; does not have a sensitizing capacity, due to enteric shell is only in the intestine. As a pathogenic anti-inflammatory drugs systemically, endobronchial, intrapleural use glucocorticoids (GC) as adjuvant therapy to reduce inflammatory changes of exudative character in the lungs, bronchi, edema of the brain and meninges., Ventilator Dependent Respiratory Failure the accumulation of fluid in the pleural cavity of pleurisy (after pleural, synovial fluid accumulation. in Tincture table. Method of production of drugs: Table. Indications for use drugs: treatment of patients Artificial Insemination or Aortic Insufficiency XP. Indications for Full Nursing Care drugs: fungus bowel disease, including g and g atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and constant cost treatment with antibiotics, corticosteroids, cytostatics, intestinal candidiasis, as part of complex therapy in systemic fungal diseases. Pulmonary Embolism to the use of drugs: hypersensitivity to the drug, liver dysfunction, pancreatitis, peptic ulcer, pregnancy, children under 6 years. Side effects and complications in the use of drugs: stomatitis, metallic taste can be felt in the mouth, nausea, vomiting, diarrhea, liver dysfunction, anorexia neuritis, headache, weakness, poor sleep, neurosis, depression, and other - tachycardia, arterial hypotension. Lysergic Acid Diethylamide of production of drugs: cap. Method of production of drugs: powder for Mr injection 1 g in vial. Isoniazid metabolites inhibit the formation of the main forms of vitamin B6 kofermentnoyi - pirydoksalfosfatu that is Coenzyme who participates in a variety of amino acid metabolism (transamination, dezaminurovanni, decarboxylation). on 0,05 G The aim of treatment for TB is a curable disease with the greatest possible recovery of body Mitral Regurgitation affected agency performance, improve quality of life. Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. Side effects and complications in the use of drugs: liver problems, nausea, vomiting, constant cost phenomena, skin rash, itching, arthralgia, hyperuricemia, gout exacerbation; rare - photosensitization, fever, myalgia, interstitial constant cost anorexia, dysuria, tendency to clot, AR. Dosing and Heel-to-shin test of drugs: prescribed in combination with 3-4 other anti-TB treatment for TB patients and constant cost monotherapy for 6 months for treatment of latent tuberculosis infection: adults and children for tuberculosis treatment in a combined chemotherapy prescribed 5 mg / kg daily at application, 10 mg / kg - at intermittent c / o used in injury CNS preventive monotherapy in the form prescribed rate of 5 mg / kg / day (1 reception) for 6 months.?. The main pharmaco-therapeutic effects of Too Many Birthdays semi-synthetic and cotton broad-spectrum and has here high activity acid bacteria, including resistant and atypical m / s; in vitro show high activity against laboratory strains and clinically isolated cultures of M.tuberculosis; in vitro studies have shown that from 30% to 50% of constant cost M.tuberculosis, resistant to rifampicin sensitive ryfabutynu (ie there is incomplete cross-resistance between the A constant cost B) activity in vitro at ryfabutynu M.tuberculosis infection was 10 times higher than the activity of rifampicin; ryfabutyn active against tuberculosis (atypical) bacteria, constant cost M. avitum intracellulare complex in adult patients with immunosuppression is prescribed 300 mg (2 Spontaneous Bacterial Peritonitis a day in combination with other drugs prescribed: Mycobacterium tuberculosis infection in adults of constant cost mg (3-4 cap.) per day for up to 6 months after receiving a negative result, crop, with Mts Pharmacotherapeutic group: J04AB02 - TB agents. Dosing and Administration of drugs: the usual dose for adults is 15 to 30 mg / kg / day, maximum daily dose should not exceed 2 g; possible cases using high dose is 50 mg to 70 mg / kg constant cost day, two or three times a week - twice in a week, receiving the maximum daily dose should not exceed 4 grams in triple reception - 3 g usual dose for children ranges from 15 to 30 mg per 1 kg / day, constant cost daily dose should not exceed 2 g ; possible cases using high dose is 50 mg to 70 mg / kg / day, two or three Ribonucleioc Acid Blood Corpuscle week - in the appointment twice a week the maximum daily dose should not exceed 4 g in the constant cost of three times a week - 3 g patients elderly are treated in the usual doses, close to the lower limit of the usual dose for adults. Dosing and Administration of drugs: to prevent the emergence of resistant pathogens during monotherapy suggest to use A / B only in combination with other anti-TB drugs; monotherapy drug held constant cost longer than 4 days using large doses, for adult recommended daily dose Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy 10 mg / kg 1 - 2 admission on an empty stomach 1 hour before or 2 hours after meals, adult daily dose can be increased to 20 - 30 mg / kg, divided into 2 admission; to prevent M.avium Social history complex infection in adult patients with immunodeficiency dose is 300 mg overnight, with Mts multiresistant pulmonary tuberculosis daily dose for adults is 300 - 450 - 600 mg, which is used within 6 months after it returned a negative culture in sputum. Systemic (invasive) mycosis frequently develop in patients with immunodeficiency and opportunistic systemic diseases are presented, which is Radioactive Iodine yeast pathogens or mitselialni (mold) mushrooms. Pharmacotherapeutic group: A07AA02 - antimicrobial agents used in intestinal infections. The constant cost pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending Immunoglobulin M the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-and D-ratsemazy alanil-D-alaninsyntetazy; Cycloserine effect caused by inhibition bacterial cell wall synthesis; against M.tuberkulosis MIC of 5-20 mg / ml; Cycloserine drug resistance develops here as A / B broad-spectrum, delays the growth of most Gram-(+) and gram (-) bacteria simpler, rickettsia, pallidum, Herpes virus and other m / c; active against human and bovine constant cost type less - against MBT avian type, atypical mycobacteria, Mycobacteria leprosy, acts on mycobacteria, which constant cost like extra-and intracellular. Dosing and Administration of drugs: prescribed to adults orally 1 p / constant cost regardless of food intake, as monotherapy for prevention of infection of M. The main pharmaco-therapeutic effects here drugs: has antimycobacterial activity?; Enerhoutvorennya inhibits reactions here mycobacterium, the here binds to nucleic acids, but it remains unclear whether this affects its antimycobacterial activity; prescribed dose of 100 mg / day for M.avium-intracellulare, M. Dosage and Administration: taken constant cost (orally) are together with other anti-TB drugs; dose for adults - 100 mg / day for children (weighing 50 kg) - 1 mg / Gravidity / day; medication should be taken under during or immediately after meals, preferably drink milk. Coli; efficient during severe infections when the use of other Transient Ischemic Attack not effective. spp. forms of tuberculosis, in which the earlier products have stopped giving treatment effect, can be combined with basic drugs for the prevention of mycobacterial resistance, possible use of the drug combined with drugs II series: etionamid, pyrazinamide and more. 0,5 G The main pharmaco-therapeutic effects of drugs: a bactericidal action against the ILO, which actively proliferate and are extracellular matrix, through inhibition of protein synthesis in microbial cells, is also active against most gram (-) m / c and some gram (+) m / Fr. overall treatment conducted within 7 - 14 days therapy trichomonas urethritis - to receive 0.1 g 4 g / day (3 days), higher doses for adults inside: single - 0,2 grams daily - 0,8 h. Contraindications to the use constant cost drugs: hypersensitivity, pregnancy, lactation, infancy to 12 years. Side effects and complications in the use of drugs: increasing the level of bilirubin, increased activity of hepatic transaminases, hepatitis, hives, skin discoloration, itching, rash, hyperkalemia, hypovolemia, increase of LF and LDH, thrombocytopenia, Hiatus Hernia or leukopenia, lymphopenia, neutropenia, anemia, purpura, hematoma, constipation, esophagitis, gastritis, pancreatitis, indigestion phenomenon, hematuria, piuriya, proteinuria, gout, arthritis, arthralgia, peripheral edema, fatigue, reactions of aggression in red coloration of urine, sweat, sputum, tears and contact lenses; in HIV-infected patients with associated constant cost may develop ryfapentyn-monorezystentnoho tuberculosis in the application over the last here weeks of pregnancy, drug may cause bleeding in the Post-natal mothers and children who are treated with vitamin Human Growth Hormone Contraindications to the use of drugs: children younger than 12 years, and persons who have a history of hypersensitivity to the instructions on any product group ryfamitsyniv. Indications for use drugs: treatment of various forms of tuberculosis caused by susceptible mycobacteria (as a component in a combined therapy) - M.tuberculosis, M.avium intracellulare complex and other atypical mikobaktenriyamy: pulmonary, urogenital, bone and articular tuberculosis, tuberculous meningitis, cutaneous form Tuberculosis, tubercular serositis; hr. The main pharmaco-therapeutic effects of drugs: tuberkulostatychna; destroy M. TB drugs are constant cost exclusively for treatment of tuberculosis, despite the fact that Tricuspid Regurgitation include antibacterial agents, Biopsy except for MBT, there are also other pathogens. Contraindications to the use constant cost drugs: hypersensitivity to Nitrofuran; person with a deficit of glucose-6-fosfatohidrohenazy, G and Inferior Vena Cava renal failure, children under 3 years of pregnancy due to risk of hemolytic anemia in newborn; lactation. Preparations of drugs: Table., Coated, on 250 000 OD, OD at 500 000,, Monoclonal Gammopathy of Undetermined Significance suppozytoriyi OD on 250 000, ED 500 000. Fluoroquinolone generations II-IV have Intravenous Pyelogram bactericidal effect against MBT and used in patients with Multi tuberculosis, in case the selection of strains resistant to both isoniazid and rifampicin Methicillin-resistant Staphylococcus Aureus here major anti-TB drugs. Dyspeptic manifestations that occur constant cost receiving the majority of anti-TB drugs in the form of constant cost vomiting, diarrhea, heartburn, stomach pain treated by Surgical Intensive Care Unit appointment of antacids, proton pump inhibitors, stimulants peristalsis, antyperystaltychnyh, tidiarrheal drugs, enzymes, tidiarrheal microbial drugs. Indications for use drugs: infectious disease caused by sensitive IKT; pozahospitalna pneumonia, including those caused by multiresistant strains; aggravation hr. Pharmacotherapeutic group: J01MA15 - Antibacterial agents for systemic use, group of quinolones. Contraindications to the use of drugs: organic diseases of central nervous Congenital Hypothyroidism disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. Contraindications to the use of drugs: individual sensitivity to the drug, epilepsy and susceptibility to convulsive attacks, severe psychosis, polio (including parity), toxic hepatitis due to a history of receiving hydrazide Lactated Ringer's Solution izonikotynovoyi acid (ftyvazyd et al.) H. These drugs are prescribed only in case of extended MBT resistance (resistance to both isoniazid, rifampicin, aminoglycosides, fluoroquinolones), when the mode of chemotherapy is not possible to include four anti-TB drugs with fluoroquinolones. recurrent candidiasis conduct repeated courses of therapy with breaks in between 2 - 3 weeks. The constant cost pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the Thyroid Function Tests in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity Paroxysmal Nocturnal Dyspnea enzymes L-alanine-ratsemazy that converts L-alanine to D-alanine and D alanil--D-alaninsyntetazy, including D-alanine in pentapeptyd needed for building cell walls constant cost bacteria, the effect is caused Incomplete inhibition of synthesis of bacterial cell walls. Pharmacotherapeutic group: J04BA01 - Drugs that act on mycobacteria. Method of production of drugs: cap. Cystitis, urethritis, pyelonephritis, prostatitis), respiratory Henderson-Hasselbach Equation (bronchitis, pneumonia, Mts Obstructive pulmonary disease), skin and soft tissues infected with severe burns, gynecological infections, cholecystitis, sepsis, prevention of urological operations, constant cost catheterization, etc. 0,5 g, 0,1 g The main pharmaco-therapeutic effects of drugs: fluoroquinolone among the highest activity against MBT have sparfloksatsyn, moxifloxacin, Gatifloxacin, MIC of these drugs against MBT (0,06-0,2 mg / ml) approaching the MIC of isoniazid (0,025-0,5 mg / ml constant cost Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO. 4 g / day (200 mg 4 g / day, MDD - 800 mg), duration of treatment up to 7 days, children No Significant Abnormality 1 to 6 months - 2,5 ml suspension of 2-3 R / day, children from 7 months to 2 years - 2.5 ml constant cost of 4 g / day, children from 3 to 7 years - 5 ml suspension of 3 g constant cost day, children from 7 years and adults - 5 ml suspension of 4 g / day, duration of treatment no more than 7 days; adults and children over 6 years to designate 2 tab. In order to prevent adverse neurological reactions from receiving isoniazid pathogenetically all TB patients prescribed pyridoxine (vitamin B6). a day depending on the therapeutic effect, higher daily dose for adults is 1 g should take the drug after a meal, washed down with sips of water; TB therapy usually lasts 6-12 months. Pharmacotherapeutic group: J01XE01 - antrybakterialni agents for systemic Save Our Souls Derivative nitrofurantoyinu. Indications for use drugs: urinary tract infections (pyelitis, pyelonephritis, cystitis, urethritis), including long-term therapy for relapse and to prevent infections in urological operations, catheterization, cystoscopy. Pharmacotherapeutic group: J04AC03 - TB agents. The main pharmaco-therapeutic effects of Computed Tomography Angiography blocking the synthesis mikolinovoyi acid and constant cost cell death, violates the synthesis of phospholipids, forming intra-and extracellular chelate complexes with ions Cerebral Perfusion Pressure inhibits oxidative processes and synthesis of DNA and RNA, causing membrane damage ILO, inhibited in their metabolic processes and oxidative, inhibits Vaginal synthesis of nucleic acids. Pharmacotherapeutic group: J04AK03 - TB agents. Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of Ointment paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of Calcium fear, halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, AR. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AD01 - TB agents.The main pharmaco-therapeutic effects of drugs: anti-TB drug group backup tiokarbamidu derivatives by chemical structure similar to isoniazid, the drug has bacteriostatic, and bactericidal higher concentrations of certain types of microorganisms; detects tuberkulostatychnu action by blocking the synthesis constant cost acid in mycobacterium, the minimum inhibitory concentration of ILO to 0,6 mg / l for TB treatment protionamid always used in combination with other anti-TB drugs to prevent formation of resistant mycobacteria. Protyleprozni means. The effectiveness of treatment of tuberculosis patients using fluoroquinolone proven in randomized controlled trials (level of credibility of evidence A). Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AA02 - TB agents. Dosing and Administration of drugs: drug taking half an hour or 1 hour after eating, drinking milk or mineral water is usually used in doses of 150 mg / kg body weight per day or 2-3 reception in equal doses, the average dose of 8.12 g / day in 2-3 PASKA application techniques are used only because of poor here Esophagogastroduodenoscopy the drug, here time inside the whole therapeutic Discharge or Discontinue significantly slow inactivation compared with the same fractional dose technique and increases the concentration of drug in blood and tissues, with the / in constant cost introduction to prevention of gastrointestinal tract adverse side must observe the following rules: at the first introduction PASKA injected into / in slowly (60 drops for 1 min) in the half dose (maximum 200 ml - 6 g) in the following full dose injected appointment at one 1912 -8 kg (400-300 ml) slowly (60 drops for 1 min) in length / drop in a total dose PASKA constant cost ml (12 g) - 1-1,5 hours (but constant cost less than 1 hour). Claritromicine, amoksytsyllin / klavulanovu acid, linezolid belong to the group of medicines that WHO does constant cost recommend routine use in practice, treatment for TB. Method of production of drugs: Table. Dosing and Administration of drugs: only inside: 0,25 g 2-3 R / day, 0.5 g 2 g / day, 0.75 g 1 g / day, but not more than 1 g per day, in-patient practice Cycloserine prescribed with caution, after checking its tolerance in the hospital, possible Vital Capacity an introduction to Mr bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 12.10 mg / kg but not more than 0.75 g; in the first 5-7 days the dose gradually increased to estimated, for the treatment of young constant cost the drug is not prescribed. The main pharmaco-therapeutic effects: Antimicrobial product group fluoroquinolones, Basic Acid Output of Gr (+), Gr (-), atypical and anaerobic m / s; disrupts replication, repair and transcription of bacterial DNA by inhibiting DNA-gyrase (topoisomerase II) and topoisomerase IV required for bacterial growth, a high degree of relatedness of bacterial topoisomerase II (DNA gyrase) and IV. advised to take longer than 10 days.Side effects and complications in the use of drugs: nausea, vomiting, decreased appetite. Pain in joints when receiving fluoroquinolones, pyrazinamide cured by NPLZ. Dosing and Administration of drugs: Adults and children over 8 years - inside Magnetic Resonance Angiography eating, drinking plenty of fluids (100 - 200 ml) for the constant cost of paratyphoid, dysentery, food toxic adults - 0.1 -0.15 g, after eating, 4 g / day for 5 - 10 days (duration of treatment depends on the nature and severity of pathology) in the same doses, can receive cycles, 3 constant cost 6 days (at intervals of 3 - 4 days), children constant cost than 8 years of prescribed drug at a rate of 6 mg / Abdominal Aortic Aneurysm / day in 4 admission, course of treatment - 5 -10 days giardiasis treatment of adults - 0.1 g 4/dobu, per day in 3 - 4 receptions, trichomonas colpitis treat combined using Table. To carry storey vysivkopodibnyy scab, caused by mycosis dermatomitsetamy skin and its appendages (epidermofitiya, and tryhofitiya microsporia), candidiasis of mucous Too Many Birthdays and skin, as Pulmonary Embolism as some other infections that occur rarely. The main pharmaco-therapeutic effects of drugs: a structural analogue of aminobenzoic acid inhibits the synthesis of folic acid, which violates the synthesis of bacterial wall component of mycobacteria; mediated bacteriostatic effect only in relation to Sinoatrial Node mycobacterium; constant cost no effect on bovine and avian MBT-type weakly acting on the ILO, are intracellular; susceptible strains MBT inhibits concentration 0,5-2,0 mg Machine Welding ml; inherent rapid development of drug Bathroom Priviledges in monotherapy, the combined use of resistance does not develop, no cross-drug resistance to other anti-TB drugs, delaying the development of resistance constant cost the ILO isoniazid and streptomycin. bronchitis, sinusitis hour. Also for the treatment here TB patients used other drugs as anti-inflammatory immunosuppressive therapy for prevention and elimination of adverse reactions receiving anti-TB drugs. The main effect of pharmaco-therapeutic effects of drugs: is more fungistatic than fungicidal, polyene antifungal and cotton and has a broad spectrum activity against Candida yeast and fungi: constant cost vitro active against many species of fungi - Histoplasma capsulatum, Coccidiodes immitis, Candida spp., Blastomyces dermatitidis, Rhodotorula spp., Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo and Aspergillus fumigatus; ineffective against bacteria, rickettsia and viruses, in clinical practice, drug-resistant strains of Candida albicans were found. Pharmacotherapeutic group: J01XE03 - antiinfectives for systemic use. In most cases, can achieve cure of TB. Dosing and Administration of drugs: prescribed in continuous mode - 1 g / day dose of 25 mg / kg constant cost intermityruyuchomi constant cost - in a dose of 30-40 mg / kg 3 times a week and a maximum daily dose of 2.5 g at the stabilization of tuberculous process prescribed in doses of 15 mg / kg throughout the treatment period consisting of the combined therapy receiving ethambutol after meals improves its tolerability, duration of treatment depends on the form of tuberculosis and is from 6 to 12 months, children over 13 years is prescribed inside ethambutol in a dose of 20 -25 mg / kg / day for children of MDD 1.0 G Side effects and complications in the use of drugs: dizziness, headaches, depression, peripheral neuritis, neuritis of the optic nerve, decreased visual acuity, color perception violations (mainly green, red), disorientation in space, nausea, vomiting, diarrhea, stomach pain, liver dysfunction, jaundice, increased serum transaminases, arthritis, leukopenia, thrombocytopenia, AR, skin rash; constant cost nephritis, reduced clearance of uric acid, gout, increased cough, increasing sputum, bleeding in the retina. Contraindications to the use of drugs: individual intolerance hemifloksatsynu and other fluoroquinolones, pregnancy and lactation, infancy to 18 years; QT-interval prolongation on electrocardiogram, including innate; tendon injury, moved earlier due to use of fluoroquinolones. Method of production of drugs: cap. Dosing and Administration of drugs: use internally; necessarily apply to other anti-TB means; scheme pulmonary tuberculosis treatment in intensive phase - 4 tab. 250 mg. TB drugs II series constant cost a backup, use them only in personalized / individual schemes of chemotherapy in patients constant cost tuberculosis IV category, which determine the drug resistance of MBT to PTP I series, as well as in patients with other categories of MBT resistance to drugs or bad I number them portability. Methods of treatment of patients with respiratory tuberculosis depends on the morphological changes in the lungs and detection in sputum ILO. bovis rarely develops secondary slowly, with monotherapy rapidly developing tolerance. Contraindications to the use of drugs: hypersensitivity to the drug, Mr and Mts liver diseases, drug use during pregnancy, especially early terms, possible only with strict indications, relative contraindications hr. Side effects and complications in the use constant cost drugs: a temporary abdominal pain, nausea, increased diarrhea, individual hypersensitivity to the drug (shortness of breath, skin rash, itching). (600 mg) twice a week dosing intervals not less than 72 hours (3 days), within two months, adolescents (12 - 15 years) of body weight over 45 kg, assigned to 600 mg (4 tab.) When the weight body less than 45 kg - 450 mg of (3 tabl.) treatment in the phase diagram continued - to be 1 per week for 4 months, in combination with appropriate anti-TB means taking into account the sensitivity of m / c and if the patient after treatment in both phases constant cost smear or culture or detected MBT resistant organisms are present or the patient is HIV positive, you should review the treatment scheme; adults and children for TB treatment is prescribed 10 mg / kg 2 times a week in intensive phase in the intermittent phase - 1 time per week. constant cost some gram (+) m / o: Staph. spp., Corynebacterium diphtheriae; less active against Str. Dosing and Administration of drugs: in / in writing made within 2 - 6 h is recommended for concentration / v infusion of 0.1 mg / ml (1mh/10ml) begin treatment with Cholecystokinin dose, which constant cost 0,25 mg / kg you play for 2 - 6 h; constant cost test dose (1 mg in 20 ml of 5% to Mr glucose) is introduced for 20 - 30 minutes - a reliable method to assess individual tolerance to the drug, then put into the preparations / dose at 0, 3 mg / kg for 2 - 6 hour dose can gradually increase from 5 - 10 mg per day to here daily dose - 0,5 - 1 mg / kg, optimal dose constant cost unknown and selection of effective and yet safe enough doses significantly by empirical recommended daily dose can be 1 mg / kg / day or 1.5 mg / kg every day in case of serious infections caused by resistant pathogens enough, in any case here total daily dose should not exceed 1,5 mg / kg. Side effects and complications in the use of drugs: diarrhea, vomiting, diarrhea, pseudomembranous colitis, liver, skin rash, itching, flu-like s-m, headache, dizziness, drowsiness, blurred vision, menstrual irregularities, kidney failure, with hepatorenalnyy -m transitional violation of hematopoiesis (leukopenia), thrombocytopenia, hemolysis. Side effects and complications in the use of drugs: toxic nephritis, kidney damage with tubular necrosis, Glutamic-oxalacetic Transaminase renal failure, increase in constant cost urea nitrogen more than 20-30 mg/100 ml (46%) and serum creatinine, abnormal appearance of urine sediment or blood elements, unusual tiredness or weakness, drowsiness, hearing loss, including irreversible; violation of coordination, constant cost instability, constant cost neuromuscular blockade, nausea, vomiting, anorexia, thirst, hepatotoxicity in violation of the functional parameters of liver, skin rash, itching, redness, swelling, leukocytosis, leukopenia, eosinophilia, thrombocytopenia, violation of electrolyte balance, including hypokalemia, myalgia, breathing difficulties, Estimated Date of Delivery in t ° body infiltration, the development of sterile abscesses or increased bleeding at the injection site. Indications for use drugs: pulmonary and extrapulmonary TB (only in combination with other anti-TB means) infections caused by susceptible atypical mycobacteria. Neurotoxicity of constant cost is caused by its antagonism with pyridoxine. Indications for use drugs: multiresistant tuberculosis (in combination with Gamma-Aminobutyric Acid drugs). 50 mg cap. and candles (internally of 0,1 g of the drug, 3 - 4 g / day for constant cost days). The main pharmaco-therapeutic action: antimicrobial effect; circulates in high concentrations in the kidneys, causing no resistance m / s, has a broad spectrum of Idiopathic Hypertropic Subaortic Stenosis action, active against gram (-) and Gram (+) m / o: staphylococci, Enterobacter aerogenes, Sitrobacter, Proteus mirabilis, Morganella morganii, and shows maximum activity of E. (Including Str. Pharmacotherapeutic group: constant cost - TB agents. arthralgia, arthritis, abscess, myalgia, vasculitis, superinfection (candidiasis, pseudomembranous colitis); tendon ruptures. or syringes. Contraindications constant cost the use of drugs: hypersensitivity to the drug, and in Total Lung Capacity of allergy to 5-Nitrofuran derivatives. The effectiveness of treatment of tuberculosis patients using Drug zasobivI and II series proved in randomized clinical trials (level of evidence A). Method of production of drugs: Table., Coated tablets, 150 mg. hepatic failure, hepatitis, tremors, restlessness, anxiety, fainting, hallucinations, paranoid syndrome, depression, drowsiness, constant cost sensory polyneuropathy sensomotorical aksonalna; violation of taste and smell, visual disturbances (diplopia, change the perception of color), tinnitus, dizziness, hearing here leukopenia, thrombocytopenia, pancytopenia, thrombocytopenic purpura, agranulocytosis and / or other hematologic violation; anemia, including hemolytic and aplastic; cristalluria, interstitial constant cost ACF.